Seeking Alpha

AVNR
Avanir Pharmaceuticals, Inc - NASDAQ

4/16/2014, 4:31 AM ET
Quote & Analysis Breaking News StockTalk
avnr chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There is research on this stock available only to PRO subscribers.
Other Articles
AVNR vs. ETF Alternatives
Company Description

Avanir Pharmaceuticals is a biopharmaceutical company engaged in acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders.